Cancer clinical trials in the region Auvergne-Rhône-Alpes
286 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 1 / Phase 2
Lymphoma
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M4
T cell lymphoma
Peripheral T cell lymphoma
None
1
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2
Lymphoma
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M4
B cell lymphoma
Large B cell lymphoma
None
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2
Breast cancer
Lung cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M1
Urothelial carcinoma
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2
Endometrial cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M3
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2
Lung cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M5
Mesothelium
Locally Advanced
Metastatic
Other mutation
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2
Pancreas cancer
#NCT05706129
Adenocarcinoma
Locally Advanced
Metastatic
1
2
3 or more
Chemotherapy
Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand )
Debiopharm International SA
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT05706129
Locally Advanced
Metastatic
1
2
3 or more
Chemotherapy
Targeted therapy
Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand )
Debiopharm International SA
Phase 1 / Phase 2
Kidney cancer
#NCT05706129
Clear cell carcinoma
Locally Advanced
Metastatic
2
3 or more
Targeted therapy
Immunotherapy
Targeted therapy
Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand )
Debiopharm International SA
Phase 1 / Phase 2
Kidney cancer
#NCT05706129
Other
Localized
None
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand )
Debiopharm International SA
Phase 1 / Phase 2
Breast cancer
Lung cancer
#NCT05706129
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
HER2 Negative
HR Negative
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand )
Debiopharm International SA